Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
On CNBC-TV18's show Super Six, market gurus Vishal Malkan of www.malkansview.com, Shardul Kulkarni of Angel Broking and Arunesh Madan, Founder and Director of Augment Investment, place their bets on two stocks each, thus offering investors a variety of options to choose from.
In CNBC-TV18's popular show Bull's Eye, Parag Doctor, Keynote Capital, Fort Share Broking shares trading strategy of the day.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
In CNBC-TV18's popular show Bull's Eye, Parag Doctor, Keynote Capital, Fort Share Broking shares trading strategy of the day.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
On CNBC-TV18's show Super Six, market gurus Vishal B Malkan of www.malkansview.com, Shardul Kulkarni of Angel Broking and Rajesh Jain of Religare Securities, place their bets on two stocks each, thus offering investors a variety of options to choose from.
Sudarshan Sukhani of s2analytics.com is of the view that one can short Ranbaxy and Divis Laboratories.
Ashish Chaturmohta of IIFL Private Wealth Management is of the view that one buy Divis Laboratories, Ranbaxy Laboratories, Hindustan Unilever on any decline.
Sudarshan Sukhani of s2analytics.com is bullish on Divis Laboratories and TCS and has recommended buy rating to the stocks.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
On CNBC-TV18's show Super Six, market gurus Vishal Malkan of malkansview.com, Rajesh Jain, Religare Securities and Manas Jaiswal of manasjaiswal.com, place their bets on two stocks each, thus offering investors a variety of options to choose from.
On CNBC-TV18's show Super Six, market gurus Vishal Malkan of malkansview.com, Rajesh Jain, Religare Securities and Manas Jaiswal of manasjaiswal.com, place their bets on two stocks each, thus offering investors a variety of options to choose from. Investors can read into the detailed analysis before agreeing to any or all the bets.
Shrikant Chauhan of Kotak Securities, advise traders to buy Divis Labs.
CNBC-TV18 brings you a brand new week of Bull's Eye. It's the popular game show where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
Amit Gupta, ICICI Direct is of the view that one can buy Divis Laboratories.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
Sudarshan Sukhani of s2analytics.com shares his view on Divis Laboratories.
Divis Labs, Ipca Labs and Glenmark Pharma are defensive bets in pharma sector, says Sudip Bandyopadhyay, MD & CEO, Destimoney Securities.
Ashish Chaturmohta, VP Derivates and Technicals, IIFL Private Wealth Management is of the view that Divis Laboratories can touch Rs 780-790.
Dr Reddy, Divis Labs and Lupin may give 10-15% gains, says Dilip Bhat, Joint MD, Prabhudas Lilladher.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
CNBC-TV18 brings you a brand new week of Bull's Eye. It's the popular game show where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.
Buy Aban Offshore at current levels, says Sudarshan Sukhani, s2analytics.com.
Accumulate Divis Lab at current levels, says Sudarshan Sukhani, s2analytics.com.